CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders

Astrocytic impairment is a pathologic feature of neuromyelitis optica spectrum disorder (NMOSD). S100B and glial fibrillary acidic protein (GFAP) are the two most commonly used astrocytic markers. The aim of this study was to evaluate whether CSF-S100B could serve as a marker of NMOSD. We enrolled 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yuzhen, Chang, Haoxiao, Li, Xindi, Du, Li, Xu, Wangshu, Cong, Hengri, Yao, Yajun, Zhang, Xinghu, Yin, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217894/
https://www.ncbi.nlm.nih.gov/pubmed/30426010
http://dx.doi.org/10.1155/2018/5381239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217894/
https://www.ncbi.nlm.nih.gov/pubmed/30426010
http://dx.doi.org/10.1155/2018/5381239

Ejemplares similares